热门资讯> 正文
印度太阳制药完成与塔罗的合并
2024-06-24 20:02
- Sun Pharmaceutical said on Monday that the India-based specialty generics company has completed its merger with the Israel-based Taro Pharmaceutical Industries (NYSE:TARO).
- Sun Pharma acquired all the outstanding ordinary shares of Taro that it did not previously own for $43 per share.
- Sun Pharma has been the majority shareholder of Taro since 2010, and the present deal makes Taro a private company.
- Source: Press Release
More on Taro Pharmaceutical
- Seeking Alpha’s Quant Rating on Taro Pharmaceutical
- Financial information for Taro Pharmaceutical
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。